Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model

被引:34
作者
Lu, Mengji [1 ]
Yao, Xin [2 ]
Xu, Yang [1 ]
Lorenz, Heike [3 ]
Dahmen, Uta [4 ]
Chi, Haidong [4 ]
Dirsch, Olaf [5 ]
Kemper, Thekla [1 ]
He, Lifang [2 ]
Glebe, Dieter [3 ]
Gerlich, Wolfram H. [3 ]
Wen, Yumei [2 ]
Roggendorf, Michael [1 ]
机构
[1] Univ Klinikum Essen, Inst Virol, D-45122 Essen, Germany
[2] Fudan Univ, Med Ctr, Dept Mol Virol, Shanghai 200433, Peoples R China
[3] Univ Giessen, Inst Med Virol, Giessen, Germany
[4] Univ Klinikum Essen, Klin Allgemein Viszeral & Transplantat Chirurg, Essen, Germany
[5] Univ Klin Koln, Inst Pathol, Cologne, Germany
关键词
D O I
10.1128/JVI.01613-07
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The essential role of multispecific immune responses for the control of hepatitis B virus (HBV) infection implies the need of multimodal therapeutic strategies for chronic HBV infection, including antiviral chemotherapy and immunomodulation. This hypothesis was tested in the woodchuck model by a combination of lamivudine pretreatment and subsequent immunizations of woodchucks chronically infected with woodchuck hepatitis virus. The immunizations were performed with DNA vaccines or antigen-antibody immune complexes (IC)/DNA vaccines. Immunizations with IC/DNA vaccines led to an anti-woodchuck hepatitis virus surface antibody response and significant reductions of viral load and antigenemia, suggesting that such a strategy may be effective against chronic HBV infection.
引用
收藏
页码:2598 / 2603
页数:6
相关论文
共 46 条
[21]   Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks [J].
Lu, M ;
Isogawa, M ;
Xu, Y ;
Hilken, G .
JOURNAL OF VIROLOGY, 2005, 79 (10) :6368-6376
[22]   Immunomodulation as an option for the treatment of chronic hepatitis B virus infection: preclinical studies in the woodchuck model [J].
Lu, Mengji ;
Menne, Stephan ;
Yang, Dongliang ;
Xu, Yang ;
Roggendorf, Michael .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (06) :787-801
[23]   Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection [J].
Lu, MJ ;
Hilken, G ;
Kruppenbacher, J ;
Kemper, T ;
Schirmbeck, R ;
Reimann, J ;
Roggendorf, M .
JOURNAL OF VIROLOGY, 1999, 73 (01) :281-289
[24]   Induction of antibodies to the PreS region of surface antigens of woodchuck hepatitis virus (WHV) in chronic carrier woodchucks by immunizations with WHV surface antigens [J].
Lu, MJ ;
Klaes, R ;
Menne, S ;
Gerlich, W ;
Stahl, B ;
Dienes, HP ;
Drebber, U ;
Roggendorf, M .
JOURNAL OF HEPATOLOGY, 2003, 39 (03) :405-413
[25]   Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model [J].
Lu, MJ ;
Roggendorf, M .
INTERVIROLOGY, 2001, 44 (2-3) :124-131
[26]   The role of virus-specific CD8+ cells in liver damage and viral control during persistent hepatitis B virus infection [J].
Maini, MK ;
Boni, C ;
Lee, CK ;
Larrubia, JR ;
Reignat, S ;
Ogg, GS ;
King, AS ;
Herberg, J ;
Gilson, R ;
Alisa, A ;
Williams, R ;
Vergani, D ;
Naoumov, NV ;
Ferrari, C ;
Bertoletti, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (08) :1269-1280
[27]   Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers [J].
Mancini-Bourgine, M ;
Fontaine, H ;
Scott-Algara, D ;
Pol, S ;
Bréchot, C ;
Michel, ML .
HEPATOLOGY, 2004, 40 (04) :874-882
[28]   Lamivudine therapy of WHV-infected woodchucks [J].
Mason, WS ;
Cullen, J ;
Moraleda, G ;
Saputelli, J ;
Aldrich, CE ;
Miller, DS ;
Tennant, B ;
Frick, L ;
Averett, D ;
Condreay, LD ;
Jilbert, AR .
VIROLOGY, 1998, 245 (01) :18-32
[29]   Characterization of T-cell response to woodchuck hepatitis virus core protein and protection of woodchucks from infection by immunization with peptides containing a T-cell epitope [J].
Menne, S ;
Maschke, J ;
Tolle, TK ;
Lu, MJ ;
Roggendorf, M .
JOURNAL OF VIROLOGY, 1997, 71 (01) :65-74
[30]   Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-β-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection [J].
Menne, S ;
Roneker, CA ;
Korba, BE ;
Gerin, JL ;
Tennant, BC ;
Cote, PJ .
JOURNAL OF VIROLOGY, 2002, 76 (11) :5305-5314